These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17517181)
1. Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Zhang MZ; Qiao YH; Nesland JM; Trope C; Kennedy A; Chen WT; Suo ZH Chin Med J (Engl); 2007 Apr; 120(8):663-8. PubMed ID: 17517181 [TBL] [Abstract][Full Text] [Related]
2. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [TBL] [Abstract][Full Text] [Related]
3. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350 [TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079 [TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related]
6. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365 [TBL] [Abstract][Full Text] [Related]
7. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315 [TBL] [Abstract][Full Text] [Related]
8. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Mori Y; Kono K; Matsumoto Y; Fujii H; Yamane T; Mitsumata M; Chen WT Oncology; 2004; 67(5-6):411-9. PubMed ID: 15713998 [TBL] [Abstract][Full Text] [Related]
9. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [TBL] [Abstract][Full Text] [Related]
10. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231 [TBL] [Abstract][Full Text] [Related]
12. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548 [TBL] [Abstract][Full Text] [Related]
13. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578 [TBL] [Abstract][Full Text] [Related]
14. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Davidson B; Baekelandt M; Shih IeM Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338 [TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions. Elstrand MB; Stavnes HT; Tropé CG; Davidson B Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883 [TBL] [Abstract][Full Text] [Related]
16. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome. Davidson B; Holth A; Moripen L; Trope' CG; Shih IeM Hum Pathol; 2011 Jul; 42(7):991-7. PubMed ID: 21315424 [TBL] [Abstract][Full Text] [Related]
17. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B; Shih IeM; Wang TL Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656 [TBL] [Abstract][Full Text] [Related]
19. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Reich R; Vintman L; Nielsen S; Kaern J; Bedrossian C; Berner A; Davidson B Diagn Cytopathol; 2005 Nov; 33(5):332-7. PubMed ID: 16240397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]